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Summary.-Out of 17 enzymes studied, only 9 were detectable by starch gel electro-
phoresis in mouse neuroblastoma cells in culture. Prostaglandin E1 (PGE1) and
4(-3-butoxy-4-methoxybenzyl)-2-imidazolidinone (R020-1724), a specific inhibitor
of cAMP phosphodiesterase, were used to induce " differentiation ". Lactate and
6-phosphogluconate dehydrogenases and adenylate kinase were expressed as single
bands in untreated neuroblastoma and induced " differentiated " cells, but the
electrophoretic mobility of these enzymes in PGEl-treated cells was slower than that
in malignant and R020-1724-treated cells. Three bands of glucose 6-phosphate
dehydrogenase were detectable in PGEl-treated cells, whereas the R020-1724-treated
cells had two bands and the untreated neuroblastoma cells had only one band.
Aldolase was also expressed as a single band; however, the activity of this enzyme
was much higher in PGEl-treated cells, whereas the activity was barely detectable
for R020-1724-treated and untreated neuroblastoma cells. Some of the enzymes
which are present in vivo are absent in vitro. Alkaline phosphatase is present in
brain but is absent in neuroblastoma cells in vivo and in vitro. Two bands each of
triose phosphate isomerase, fumarase and aldolase are present in brain, but only one
band of these enzymes is present in neuroblastoma cells. Although PGE1 and
R020-1724 induce many differentiated functions in neuroblastoma cells in a similar
manner, PGE1 appears to change characteristically the expression of several
enzymes.
AN ELEVATION ofthe initracellular level
of cAMP in neuroblastoma cells in culture
induces many differentiated functions
which are characteristic ofmatureneurons.
These include formation of long neurites,
(Prasad and Hsie, 1971) increase in size of
soma and nucleus associated with an
increase in total RNA (Augusti-Tocco,
et al., 1973; Prasad et al., 1973) blockade of
cells in Gl-phase of cell cycle, (Prasad et
al., 1973), increase in activities of tyrosine
hydroxylase, (Richelson, 1973; Waymire,
Weiner and Prasad, 1.972) choline acetyl-
transferase (Prasad and Mandal, 1973) and
acetylcholinesterase, (Furmanski, Silver-
man and Lubin, 1971; Blume et al., 1970),
loss of tumourigenicity (Prasad, 1972) and
increase in sensitivity of adenylate cyclase
to catecholamines (Prasad and Kumar,
1974). We have shown that the muscle-
type lactate dehydrogenase (LDH-5)
which prevails in embryonic tissue (Wolf
and Engel, 1.972) is present in neuro-
blastoma cells, but absent from mouse
brain tissue (Prasad, Prasad and Prasad,
1973), indicating the re-expression of an
embryonic feature during malignant trans-
formation. In addition, it has been
reported (Bondy, Prasad and Purdy,
1974) that the amount of poly-adenylic-
(A)-containing cytoplasmic RNA is
greater in cAMP-induced " differen-
tiated" neuroblastoma cells than that in
malignant cells. These data indicate that
there may be an alteration in the expres-
sion of genetic information during theN. PRASAD AND R. PRASAD
time of " differentiation " of neuro-
blastoma cells in culture. Therefore, we
have investigated the activities of 17
enzymes in malignant and " differen-
tiated " cells. We now report the
following: (a) several of the enzymes
which are present in brain are absent in
neuroblastoma cells in vivo and in vitro;
(b) prostaglandin(PGE,)-induced changes
in the expression of enzyme pattern
are different from those induced
by 4-(-3-butoxy-4-methoxybenzyl)-2-
imidazolidinone (R020-1724), an inhibitor
of cAMP phosphodiesterase.
MATERIALS AND METHODS
Cell culture.-The procedure for culturing
mouse neuroblastoma cells has been pre-
viously described by Prasad and Hsie (1971).
Previously defined neuroblastoma clone
NBA2 (Bondy et al., 1974) was used in this
study. Neuroblastoma cells contain tyrosine
hydroxylase and acetylcholinesterase activi-
ties, but have no choline acetyltransferase
activity. The average doubling time is
about 18 h. The procedures for making
solutions were previously described (Prasad
and Hsie, 1971). Prostaglandin E1, a
stimulator of adenylate cyclase, and 4-(-3-
butoxy-4-methoxybenzyl)-2 -imidazolidinone
(R020-1724), a specific inhibitor of cAMP
phosphodiesterase (Sheppard, Wiggan and
Tsien, 1972) induce many differentiated
functions in these cells (Prasad and Kumar,
1974). Therefore, these agents were used to
induce differentiation in neuroblastoma cells
in culture. PGE1 (10 jug/ml) and R020-1724
(200 jug/ml) were added separately 24 h after
plating the cells (5 x 105) in large Falcon
plastic flasks. The drug and medium were
changed every day and cells were removed
from the flask surface, using Viokase solution,
3 days after treatment. The cells were
washed twice with phosphate buffer solution.
To prepare the cell homogenate (in vitro
study) the cells were harvested by centri-
fugation and washed twice with 0.9% saline.
The cells were then resuspended in de-
ionized distilled water to make a concen-
tration of 5x 106 cells/ml. The cell mem-
branes were then disrupted by alternate
freezing and thawing. The supernatant
obtained after the centrifugation at 10,000 g
was used for the electrophoresis.
Tumours were produced in male A/J mice
by injecting cells of clones NBA2 (Bondy
et al., 1974). The tumour was allowed to grow
for 15 days. Crude tissue extracts (in vivo
study) of tumour, brain and kidney were
prepared as described by Prasad, Prasad and
Tevethia (1972). All the samples were
subjected to vertical starch gel electro-
phoresis. The protein concentration of each
of these samples ranged from 1 8 to 2-0 mg/
ml. The buffer systems used for different
enzymes were the same as previously des-
cribed (Prasad et al., 1974). Gel slices were
stained for the following enzymes by the
routine methods (Shaw and Prasad, 1970):
dehydrogenases of lactate (LDH), malate
(MDH), glutamate (GDH), glucose-6 phos-
phate (G6PD), 6-phosphogluconate (6PGD),
hexose-6 phosphate (H6PD), and isocitrate
(IDH), a-esterase, fumarase, phospho-
glucomutase (PGM), aldolase, adenylate
kinase (AK), acid and alkaline phosphatases,
hexokinase (HK) and triose-phosphate
isomerase (TPI).
RESULTS AND DISCUSSION
In vitro system
The Table summarizes the results of
our study. Out of 17 enzymes studied,
only 9 were detectable by starch gel
electrophoresis in neuroblastoma cells in
culture. Five of these 9 enzymes showed
electrophoretic variation. LDH and
6PGD and AK were expressed as a single
band in malignant cAMP-induced and
" differentiated " cells, but the electro-
phoretic mobility of these enzymes in
PGEl-treated cells was slower than in
control (untreated neuroblastoma) cells,
R020-1724-treated cells and tumour tissue
extract. Fig. 1 shows the electro-
phoretic pattern of 6PGD. The pattern
of G6PD was interesting. Three bands of
this enzyme were detectable in PGE1-
treated cells whereas the R020-1724-
treated cells had two bands. The control
cells as well as tumour tissue extract had
only one band (Fig. 2). Aldolase was also
expressed as a single band; the activity
was much higher in PGE1-treated cells,
whereas the activity was barely detectable
for R020-1724-treated and control cells.
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TABLE.-Expression ofEnzymes ofPGE1- and R020-1724-treated Murine Neuroblastoma
Cells in Culture and in Brain and Tumour Tissues
In vitro system
t --&
I
Enzyme
IDH
Alkaline
phosphatase
Fumerase
onGPD
GDH
a-esterase
HK
H6PD
Acid phosphatase
PGM
Aldolase
AK
MDH
LDH
G6PD
6PGD
TPI
IDH
ocGPD
GDH
HK
H6PD
PGM
AK
MDH
R020-1724-
treated
cells
Presence
PGE1- ofelectro-
Control treated phoretic
cells cells variants
In vivo system
t
Presence
ofelectro-
phoretic
Tumour Brain Kidney variants
~ + +
+
+
+
+
Isocitrate dehydrogenase
cz-glycerophosphate dehydrogenase
Glutamate dehydrogenase
Hexokinase
Hexose-6-phosphate dehydrogenase
Phosphoglucomutase
Adenylate kinase
Malate dehydrogenase
+
+
+
LDH
G6PD
6PGD
TPI
+
N.D.
+
+
+
+
+
+
+
+
+
+
+
+
N.D.
+
+
N.D.
+
N.D.
Lactate dehydrogenase
Glucose-6-phosphate dehydrogenase
6-phosphogluconate dehydrogenase
Triose phosphate isomerase
Present
Absent
Not done
a b c d
FiG. 1. Starch gel electrophoretic patterns of
6PGD from differentiated neuroblastoma
cells in vitro (o, origin). Samples are: (a)
tumour tissue extract, (b) control cells, (c)
R020-1724-treated cells, (d) PGE,-treated
cells.
18
a b c d
FiG. 2.-Starch gel electrophoretic patterns of
G6PD from differentiated neuroblastoma
cells in vitro (o, origin). Samples are: (a)
PGE,-treated cells, (b) R020-1724-treated
cells, (c) control cells, (d) tumour tissue
extract.
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
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In vivo system
HK and H6PD were the only 2
enzymes which were not detectable in any
tissue (Table). IDH was present in
kidney but absent in brain and tumour
tissue. Eight of the enzymes showed
electrophoretic variation. A single band
of AK, TPI, G6PD, fumarase and 6PGD
hydrogenase was present in tumour tissue.
In the samples of brain tissue, however, 2
bands of aldolase, fumarase and TPI were
present. Two bands of fumarase and
TPI were also present in kidney tissue.
The result shows that some of the
enzymes which are present in vivo are
absent in vitro (Nos. 1-6 of Table).
Alkaline phosphate is present in brain and
kidney tissue but absent in neuro-
blastoma cells in vivo and in vitro. We do
not know if the absence of enzymes from
the tumour tissue reflects an embryonic or
a malignant characteristic or the lack of
glial components of the nervous tissue.
The presence of 2 bands of TPI, fumarase
and aldolase in brain, and the presence of
single bands ofthese 3enzymes intumours,
indicate either the loss of tissue-specific
isozyme during malignant transformation,
or that the 2nd bands ofthese enzymes are
ofglial origin and therefore may be demon-
strated in brain but not in pure neuronal
culture. Therefore, any change or lack of
it in the expression of the enzyme pattern
in " differentiated " cells when compared
to brain tissue may or may not be the
differentiated functions of mature
neurons.
Although PGE1 and R020-1724 induce
many differentiated functions in neuro-
blastoma cells in a similar manner,
(Furmanski, Silverman and Lubin, 1971,
Prasad and Kumar, 1974) PGE1 appears
to change characteristically the expression
of AK and G6PD, 6PGD and LDH.
From these data it is clear that PGE1-
treated neuroblastoma cells in culture
express different enzyme patterns from
those cells which were treated with
R020-1724. Previous studies have
shown that many differentiated
functions in neuroblastoma cells are
induced both by PGE1 and R020-1724
(Furmanski et al., 1971; Prasad and
Kumar, 1974). However, these agents
produce different types of membrane
changes (Prasad and Sheppard, 1972).
For example, R020-1724-induced
" differentiated " neuroblastoma cells do
not agglutinate, whereas PGE,-induced
" differentiated " cells agglutinate simi-
larly to malignant cells. Our present
study shows that certain enzymatic
expressions ofPGE,-treated cells are also
different from those of R020-1724-treated
cells. These data suggest that the
expression of enzyme patterns in PGE1-
treated cells is different from that of
R020-1724-treated cells, although both
agentsincreaseintracellularlevelsofcAMP
and induce many differentiated functions
in a similar manner (Furmanski et al.,
1971; Gilman and Nirenberg, 1971;
Richelson, 1973).
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